RH Nanopharmaceuticals Company
RH/Nanopharma is a pharmaceutical research and development company dedicated to treating, preventing, slowing and reversing inflammatory diseases. Inflammation is at the heart of conditions such as osteoarthritis,type 2 diabetes, acute and chronic pain, traumatic brain injury, Alzheimer’s Disease, Dry Eye Disease (DED), inflammatory bowel disorders such as ulcerative colitis and Crohn’s Disease. RH NANO has reformulated a medication called salsalate which has been used for arthritis and diabetes for over 100 years. RH NANO is proud to be the first pharmaceutical company to successfully produce a nanoparticle of salsalate to be used in all the above mentioned inflammatory disorders. Salsalate in both standard and nanoparticle size is the safest anti-inflammatory/analgesic medicine known to physicians.
Technology:
NeuroTech
Industry:
P4 Medicine
Headquarters:
Monmouth Beach, New Jersey, United States
Zip:
11-50
Founded Date:
2017-01-01
Employees Number:
11-50
Acquisitions Number:
1
Investors Number:
1
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Grant
Last Funding Type:
info@rhnanopharma.com
Register and Claim Ownership